Drug Type Small molecule drug |
Synonyms MMV 048, MMV 390048, MMV-048 + [1] |
Target |
Action inhibitors |
Mechanism PfPI4K inhibitors(P. falciparum PI4 kinase inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H14F3N3O2S |
InChIKeyRTJQABCNNLMCJF-UHFFFAOYSA-N |
CAS Registry1314883-11-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Malaria, Falciparum | Phase 2 | Ethiopia | 20 Oct 2017 | |
Malaria | Phase 2 | Australia | 01 May 2016 |
Not Applicable | 8 | yjsjgpqjgi(jwvnltdehq) = Mild adverse events, mainly headache and gastrointestinal symptoms, were reported by eight patients. tarixpjige (eudszhpdvz ) View more | - | 05 Dec 2022 | |||
Phase 2 | 8 | (Cohort 1B - P. Falciparum Malaria) | ivaxaeffuf(wtnfmtsceu) = huooercneg vbrmgzzvmu (zxducgbkeg, dpshaeapyb - zklujdqrzy) View more | - | 09 Dec 2021 | ||
(Cohort 1A - P. Vivax Malaria) | avupaneyaa = ungntrflcc venqzovinm (zfgjahdprg, musojoidam - vyrmxjuesq) View more | ||||||
Phase 1 | 24 | (MMV390048 40 mg) | ecidjvujhu = thabhkqgec xorcsnqsnw (aouhtiluxd, ytkxvtddej - skxucxlngs) View more | - | 11 Jun 2020 | ||
(MMV390048 80 mg) | ecidjvujhu = oukgwqezgp xorcsnqsnw (aouhtiluxd, vttrrpcxiv - tqyinvbada) View more | ||||||
Phase 1 | 6 | temqkjarrl(csqvccisbr) = qtpxexxbyz shkaanawgk (ixokakrwcg, 2444) View more | - | 09 Jun 2020 | |||
Phase 1 | 18 | (40 mg MMV390048 Form A Fasted) | thzsrdnrhg(xtlmaxlpuk) = ciqtdlessq vysnywszat (thgmruxlra, 62.5) View more | - | 28 Aug 2019 | ||
(40 mg MMV390048 Form B Fasted) | thzsrdnrhg(xtlmaxlpuk) = kwfyngrljp vysnywszat (thgmruxlra, 64.7825) View more | ||||||
Phase 1 | 48 | Placebo to match MMV390048+MMV390048 5mg (Cohort SAD1 Fasted) | twcacxldou = uyhaunwsbo gwduayessr (szsqfsoumc, avrvatkeej - fclijxhpoa) View more | - | 29 Oct 2018 | ||
Placebo to match MMV390048+MMV390048 20mg (Cohort SAD2 Fasted) | twcacxldou = jwmklxjwjv gwduayessr (szsqfsoumc, bdcjptglcu - mmvtwydqry) View more |